Published in J Intensive Care on March 23, 2016
[Heart in sepsis : Molecular mechanisms, diagnosis and therapy of septic cardiomyopathy]. Anaesthesist (2017) 0.82
Pathophysiology of sepsis-induced myocardial dysfunction. Mil Med Res (2016) 0.76
Sepsis-induced cardiac dysfunction and β-adrenergic blockade therapy for sepsis. J Intensive Care (2017) 0.75
Indocyanine Green-001 (ICG-001) Attenuates Wnt/β-catenin-induces Myocardial Injury Following Sepsis. J Pharmacol Pharmacother (2017) 0.75
Zymosan-Induced Peritonitis: Effects on Cardiac Function, Temperature Regulation, Translocation of Bacteria, and Role of Dectin-1. Shock (2016) 0.75
Sepsis-Induced Cardiomyopathy: Mechanisms and Treatments. Front Immunol (2017) 0.75
Blood purification treatment initiated at the time of sepsis diagnosis effectively attenuates serum HMGB1 upregulation and improves patient prognosis. Exp Ther Med (2017) 0.75
Antioxidant Therapeutic Strategies for Cardiovascular Conditions Associated with Oxidative Stress. Nutrients (2017) 0.75
Brain-Derived Neurotrophic Factor Attenuates Septic Myocardial Dysfunction via eNOS/NO Pathway in Rats. Oxid Med Cell Longev (2017) 0.75
Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med (2001) 51.99
Pathogen recognition and innate immunity. Cell (2006) 44.14
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med (2013) 39.56
Toll-like receptor signalling. Nat Rev Immunol (2004) 34.74
Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature (2010) 11.24
DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol (2006) 10.73
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med (2009) 6.73
Septic shock. Lancet (2005) 6.67
Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med (1990) 5.15
Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet (2002) 4.42
Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc Natl Acad Sci U S A (2009) 3.99
Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med (1984) 3.81
Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science (1992) 3.80
Patterns of septic shock in man--a detailed study of 56 patients. Ann Surg (1967) 2.79
Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med (1989) 2.69
Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med (1996) 2.50
Red blood cells express a functional endothelial nitric oxide synthase. Blood (2005) 2.30
A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest (1985) 2.26
Reevaluation of the role of cellular hypoxia and bioenergetic failure in sepsis. JAMA (1992) 2.19
Induction and potential biological relevance of a Ca(2+)-independent nitric oxide synthase in the myocardium. Br J Pharmacol (1992) 2.09
Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med (2004) 2.05
Cardiomyocyte-specific overexpression of nitric oxide synthase 3 prevents myocardial dysfunction in murine models of septic shock. Circ Res (2006) 2.02
Nitric oxide and cardiac function. Circ Res (1996) 2.01
nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction. Circulation (2005) 1.97
Circulatory and metabolic alterations associated with survival or death in peritonitis: clinical analysis of 25 cases. Ann Surg (1966) 1.97
Evidence of myocardial hibernation in the septic heart. Crit Care Med (2005) 1.94
Sepsis/septic shock: participation of the microcirculation: an abbreviated review. Crit Care Med (1996) 1.94
The role of oxidative stress in the genesis of heart disease. Cardiovasc Res (1998) 1.85
The coronary circulation in human septic shock. Circulation (1986) 1.83
Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med (2005) 1.83
Lipopolysaccharide induces oxidative cardiac mitochondrial damage and biogenesis. Cardiovasc Res (2004) 1.80
Infusion of the beta-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats. Crit Care Med (2005) 1.73
Prevention of endotoxin-induced sarcoplasmic reticulum calcium leak improves mitochondrial and myocardial dysfunction. Crit Care Med (2008) 1.70
Cardiac troponins I and T are biological markers of left ventricular dysfunction in septic shock. Clin Chem (2000) 1.65
Circulating Histones Are Major Mediators of Cardiac Injury in Patients With Sepsis. Crit Care Med (2015) 1.63
Increased troponin in patients with sepsis and septic shock: myocardial necrosis or reversible myocardial depression? Intensive Care Med (2001) 1.61
Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility. Am J Physiol (1999) 1.55
Proteolytic cleavage of high mobility group box 1 protein by thrombin-thrombomodulin complexes. Arterioscler Thromb Vasc Biol (2008) 1.51
Endotoxin-induced heart dysfunction in rats: assessment of myocardial perfusion and permeability and the role of fluid resuscitation. Crit Care Med (2006) 1.51
Characterization of a myocardial depressant factor in meningococcal septicemia. Crit Care Med (2002) 1.50
A cardiodepressant factor isolated from blood blocks Ca2+ current in cardiomyocytes. Am J Physiol (1991) 1.49
Persistent preload defect in severe sepsis despite fluid loading: A longitudinal echocardiographic study in patients with septic shock. Chest (1999) 1.46
Left ventricular systolic and diastolic function in septic shock. Intensive Care Med (1997) 1.45
Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock. Circulation (1987) 1.44
Gram-negative sepsis. Background, clinical features, and intervention. Chest (1991) 1.32
Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study. Crit Care Med (2001) 1.23
Enhanced NO and superoxide generation in dysfunctional hearts from endotoxemic rats. Am J Physiol Heart Circ Physiol (2002) 1.23
Sepsis-induced cardiomyopathy. Curr Cardiol Rev (2011) 1.21
Inhibition of mitochondrial permeability transition prevents sepsis-induced myocardial dysfunction and mortality. J Am Coll Cardiol (2006) 1.20
Cytokine-endothelial interactions in inflammation, immunity, and vascular injury. J Am Soc Nephrol (1990) 1.20
Competitive and noncompetitive inhibition of myocardial cytochrome C oxidase in sepsis. Shock (2004) 1.20
Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone. Crit Care Med (2007) 1.20
Administration of anti-TNF antibody improves left ventricular function in septic shock patients. Results of a pilot study. Chest (1992) 1.10
Origin of myocardial depressant factor in shock. Am J Physiol (1970) 1.09
Combined milrinone and enteral metoprolol therapy in patients with septic myocardial depression. Crit Care (2008) 1.09
TNF-alpha and IL-1 alpha inhibit both pyruvate dehydrogenase activity and mitochondrial function in cardiomyocytes: evidence for primary impairment of mitochondrial function. Mol Cell Biochem (1997) 1.08
Myocardial energy metabolism and morphology in a canine model of sepsis. Am J Physiol (1994) 1.07
Chloromethyl-X-rosamine (MitoTracker Red) photosensitises mitochondria and induces apoptosis in intact human cells. J Cell Sci (1999) 1.06
Nos3 protects against systemic inflammation and myocardial dysfunction in murine polymicrobial sepsis. Shock (2010) 1.05
Extracellular cytochrome c, a mitochondrial apoptosis-related protein, induces arthritis. Rheumatology (Oxford) (2004) 1.05
Hemodynamic and metabolic effects of selective beta1 adrenergic blockade during sepsis. Surgery (2006) 1.03
Different sensitivity of rabbit heart and skeletal muscle to endotoxin-induced impairment of mitochondrial function. Eur J Biochem (2001) 1.02
Landiolol, an ultrashort-acting beta1-adrenoceptor antagonist, has protective effects in an LPS-induced systemic inflammation model. Shock (2009) 1.01
Cardiac myocytes activated by septic plasma promote neutrophil transendothelial migration: role of platelet-activating factor and the chemokines LIX and KC. Circ Res (2004) 0.98
IRAK1 deletion disrupts cardiac Toll/IL-1 signaling and protects against contractile dysfunction. Am J Physiol Heart Circ Physiol (2003) 0.98
Recombinant thrombomodulin protects mice against histone-induced lethal thromboembolism. PLoS One (2013) 0.98
A selective inducible NOS dimerization inhibitor prevents systemic, cardiac, and pulmonary hemodynamic dysfunction in endotoxemic mice. Am J Physiol Heart Circ Physiol (2003) 0.96
Evaluation of the role of cellular hypoxia in sepsis by the hypoxic marker [18F]fluoromisonidazole. Am J Physiol (1991) 0.96
Effects of a potent peroxynitrite decomposition catalyst in murine models of endotoxemia and sepsis. Shock (2011) 0.96
Some observations on 132 patients with septic shock. Anesth Analg (1968) 0.95
Impaired energy metabolism in hearts of septic baboons: diminished activities of Complex I and Complex II of the mitochondrial respiratory chain. Shock (1999) 0.94
Cytochrome c-induced lymphocyte death from the outside in: inhibition by serum leucine-rich alpha-2-glycoprotein-1. Apoptosis (2010) 0.94
Role of extracellular histones in the cardiomyopathy of sepsis. FASEB J (2015) 0.92
Myocardial depression in shock; a survey of cardiodynamic studies. Am Heart J (1947) 0.92
[Host inflammatory and anti-inflammatory response during sepsis]. Pathol Biol (Paris) (2012) 0.91
Histone-induced damage of a mammalian epithelium: the conductive effect. Am J Physiol (1995) 0.91
Sequential cardiorespiratory patterns in septic shock. Crit Care Med (1983) 0.90
Molecular mechanisms of sepsis. Contrib Microbiol (2011) 0.88
Hemofiltrate from patients with severe sepsis and depressed left ventricular contractility contains cardiotoxic compounds. Shock (1999) 0.87
Effects of isoproterenol on myocardial structure and function in septic rats. J Appl Physiol (1985) (1999) 0.86
Pathophysiologic responses of the subhuman primate in experimental septic shock. Lab Invest (1975) 0.86
Peroxynitrite mediates the failure of neutrophil migration in severe polymicrobial sepsis in mice. Br J Pharmacol (2007) 0.86
Time course of inducible nitric oxide synthase activity following endotoxin administration in dogs. Nitric Oxide (2001) 0.85
Increase of myocardial inhibitory G-proteins in catecholamine-refractory septic shock or in septic multiorgan failure. Am J Med (1995) 0.85
Ventricular interaction and external constraint account for decreased stroke work during volume loading in CHF. Am J Physiol Heart Circ Physiol (2001) 0.85
G protein and adenylate cyclase complex-mediated signal transduction in the rat heart during sepsis. Shock (2003) 0.85
Nitric oxide induced contractile dysfunction is related to a reduction in myocardial energy generation. Cardiovasc Res (1997) 0.84
High-mobility group box 1 (HMGB1) impaired cardiac excitation-contraction coupling by enhancing the sarcoplasmic reticulum (SR) Ca(2+) leak through TLR4-ROS signaling in cardiomyocytes. J Mol Cell Cardiol (2014) 0.84
Hyperdynamic sepsis in baboons: I. Aspects of hemodynamics. Circ Shock (1991) 0.83
Maldistribution of heterogeneous coronary blood flow during canine endotoxin shock. Cardiovasc Res (1991) 0.82
Heart failure and mitochondrial dysfunction: the role of mitochondrial fission/fusion abnormalities and new therapeutic strategies. J Cardiovasc Pharmacol (2014) 0.82
Initial externalization followed by internalization of beta-adrenergic receptors in rat heart during sepsis. Am J Physiol (1996) 0.81
The interleukin-1 and interleukin-1 converting enzyme families in the cardiovascular system. Eur Cytokine Netw (1998) 0.80
Myocardial oxygen extraction ratio is decreased during endotoxemia in pigs. J Appl Physiol (1985) (1995) 0.80
Oxygen free radicals: effect on red cell deformability in sepsis. Crit Care Med (1991) 0.80
Effects of coronary hypotension and endotoxin on myocardial performance. Am J Physiol (1974) 0.80
Impairment of cardiac beta-adrenoceptor cellular signaling by decreased expression of G(s alpha) in septic rabbits. Anesthesiology (2000) 0.80
Factors affecting hemodynamics in clinical shock with sepsis. Ann Surg (1971) 0.79